GAL and cancer: While some inconsistencies are observed between studies addressing the relative expression of Gal-1 by stroma versus tumor cells probably by differences in methodological approaches, its functional impact on other cancers such as melanoma or lung carcinoma was elegantly assessed in mice by comparing the functionality of these cellular compartments under Gal-1 deficiency or wildtype conditions.